Prediction of Rituximab Hypersensitivity and Desensitization Treatment
Clinical trial NCT04610242 · UNKNOWN
Trial details
- NCT number
- NCT04610242
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2020-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.